SCHEMBL25822239

SCHEMBL25822239

CNCCOc1cccc(OCCCc2ccccc2)c1

nearest known ligand 0.64

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR1B P28222 2/20 0.64
HTR1D P28221 1/20 0.64
DRD2 P14416 3/20 0.59
DRD4 P21917 3/20 0.59
KDM4E B2RXH2 2/20 0.59
DRD3 P35462 2/20 0.59
NSD2 O96028 1/20 0.55
ALDH1A1 P00352 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
L3MBTL1 Q9Y468 2/20 0.54
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54
SIGMAR1 Q99720 1/20 0.53
GAA P10253 1/20 0.53
ATM Q13315 1/20 0.50
TAAR1 Q96RJ0 1/20 0.50
BCHE P06276 1/20 0.50
HPGD P15428 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13862383 0.92 HTR1B (0.62) HTR1BHTR1DDRD2DRD4KDM4E
SCHEMBL19291688 0.92 HTR1B (0.66) HTR1BHTR1DDRD2DRD4KDM4E
SCHEMBL25819935 0.89 MEN1 (0.62) HTR1BHTR1DDRD2DRD4KDM4E
SCHEMBL25825085 0.86 HTR1B (0.66) HTR1BHTR1DDRD2DRD4KDM4E
SCHEMBL19291789 0.85 MEN1 (0.60) HTR1BHTR1DDRD2DRD4KDM4E
SCHEMBL25822235 0.84 DRD4 (0.59) DRD2DRD4DRD3ALDH1A1SMN1; SMN2
SCHEMBL13881714 0.84 HTR1B (0.58) HTR1BHTR1DDRD2DRD4KDM4E
SCHEMBL25822256 0.84 HTR1B (0.58) HTR1BHTR1DDRD2DRD4KDM4E
SCHEMBL25822293 0.82 HTR1B (0.57) HTR1BHTR1DDRD2DRD4KDM4E
SCHEMBL4568912 0.82 KMT2A (0.53) DRD2DRD4DRD3KMT2ABCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230218549-A1 ALKOXY COMPOUNDS FOR DISEASE TREATMENT ACUCELA INC. 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230218549-A1 ALKOXY COMPOUNDS FOR DISEASE TREATMENT ALDH1A2, CLN6, AGER HTR1B 960/4885HTR1D 1401/4885DRD2 1703/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.